[1]王召华,李小虎,钱银锋,等.MRI对胰腺导管内乳头状粘液瘤良恶性的诊断价值[J].医学信息,2019,32(14):166-169.[doi:10.3969/j.issn.1006-1959.2019.14.056]
 WANG Zhao-hua,LI Xiao-hu,QIAN Yin-feng,et al.Diagnostic Value of MRI for Benign and Malignant Intraductal Papillary Myxoma of the Pancreas[J].Journal of Medical Information,2019,32(14):166-169.[doi:10.3969/j.issn.1006-1959.2019.14.056]
点击复制

MRI对胰腺导管内乳头状粘液瘤良恶性的诊断价值()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年14期
页码:
166-169
栏目:
诊疗技术
出版日期:
2019-07-15

文章信息/Info

Title:
Diagnostic Value of MRI for Benign and Malignant Intraductal Papillary Myxoma of the Pancreas
文章编号:
1006-1959(2019)14-0166-04
作者:
王召华李小虎钱银锋赵雪梅王丽娜朱婉秋侯唯姝柏 亚
安徽医科大学第一附属医院放射科,安徽 合肥 230022
Author(s):
WANG Zhao-huaLI Xiao-huQIAN Yin-fengZHAO Xue-meiWANG Li-naZHU Wan-qiuHOU Wei-shuBAI Ya
Department of Radiology,the First Affiliated Hospital of Anhui Medical University,Hefei 230022, Anhui,China
关键词:
导管内乳头状粘液瘤胰腺磁共振成像
Keywords:
Key words:Intraductal papillary myxomaPancreasMagnetic resonance imaging
分类号:
R445.2
DOI:
10.3969/j.issn.1006-1959.2019.14.056
文献标志码:
A
摘要:
目的 探讨MRI对胰腺导管内乳头状粘液性肿瘤(IPMN)良恶性的鉴别诊断价值。方法 收集2012年1月~2018年6月我院经手术病理证实的IPMN患者24例,均行MRI检查(包括MRI平扫、三期增强以及MRCP),分析IPMN MRI表现、IPMN良恶性因素,并采用ROC曲线分析IPMN肿瘤最大径及胰管扩张直径与肿瘤良恶性关系。结果 24例IPMN患者中,良性14例,恶性10例。良性与恶性在性别、肿瘤分型、病变位置间比较,差异无统计学意义(P>0.05);恶性年龄大于良性,差异有统计学意义(P<0.05)。IPMN恶性肿瘤最大径为(55.70±10.73)mm,大于良性的(34.20±7.65)mm,差异有统计学意义(P<0.05);IPMN肿瘤最大径与肿瘤良恶性关系ROC曲线分析得出:曲线下面积(AUC)为0.87,肿瘤最大径最佳临界值为46.40 mm,敏感度为85.68%,特异性为83.35%。IPMN恶性主胰管扩张最大径为(8.91±3.22)mm,大于良性的(4.82±1.33)mm,差异有统计学意义(P<0.05);IPMN胰管扩张直径与肿瘤良恶性关系ROC曲线分析得出:AUC为0.88,胰管扩张最大径最佳临界值为7.35 mm,敏感度为70.00%,特异性为85.73%。结论 MRI能很好显示胰管扩张、囊性病变、管壁内结节等特征,在评估IPMN良恶性中具有敏感性。
Abstract:
Abstract:Objective To investigate the value of MRI in the differential diagnosis of benign and malignant intraductal papillary mucinous neoplasms (IPMN). Methods 24 patients with IPMN who underwent surgical pathology from January 2012 to June 2018 were enrolled. All patients underwent MRI (including MRI, third-phase enhancement and MRCP), and analyzed IPMN MRI findings and IPMN benign and malignant factors. The ROC curve was used to analyze the relationship between the maximum diameter of the IPMN tumor and the diameter of the pancreatic duct and the benign and malignant tumors. Results Of the 24 patients with IPMN, 14 were benign and 10 were malignant. There were no significant differences in benign and malignant gender, tumor classification, and lesion location (P>0.05). Malignant age was greater than benign,the difference was statistically significant (P<0.05). The maximum diameter of IPMN malignant tumor was (55.70±10.73) mm, which was greater than benign (34.20±7.65) mm, the difference was statistically significant (P<0.05). The maximum diameter of IPMN tumor and the relationship between benign and malignant tumors were analyzed by ROC curve: curve The lower area (AUC) was 0.87, the optimal maximum diameter of the tumor was 46.40 mm, the sensitivity was 85.68%, and the specificity was 83.35%. The maximal diameter of malignant main pancreatic duct in IPMN was (8.91±3.22) mm, which was greater than benign (4.82±1.33) mm,the difference was statistically significant (P<0.05). The ROC curve analysis of the relationship between the diameter of pancreatic duct dilatation and the benign and malignant tumors of IPMN It was concluded that the AUC was 0.88, the optimal maximum diameter of the pancreatic duct was 7.35 mm, the sensitivity was 70.00%, and the specificity was 85.73%.Conclusion MRI can show the characteristics of pancreatic duct dilatation, cystic lesions, nodules in the wall, and is sensitive in the evaluation of benign and malignant IPMN.

参考文献/References:

[1]Taouli B,Vilgrain V,O'Toole D,et al.Intraducta papillary mucinoustumors of the pancrce: featrues with multimodality imaging[J].Comput Assist Yomogr,2016,26(2):219-223. [2]王大丽,周健.胰腺导管内乳头状粘液性肿瘤的影像学表现及其在术前诊断相关性浸润癌中的应用价值[J].中华肿瘤杂志,2014,36(10):9682-9687. [3]Longnecker DS,Adler G,Hruban RH,et a1.Intraductal papillary mucinous neoplasms of the pancreas Hamilton SR, Aaltonen LA.WHO classification of tumors of the digestive system[M].Lyon:IARC Press,2014,15(5):237-240. [4]蔡云龙,戎龙.胰腺导管内乳头状粘液瘤临床特征与手术指征及恶性危险因素分析[J].中华消化外科杂志,2017,16(2):996-1004. [5]王尧,王雷,范向军,等.胰腺导管内乳头状粘液肿瘤32例临床分析[J].交通医学,2015,29(6):596-598. [6]陆闪,许茂盛,喻迎星.胰腺囊性肿瘤MRI诊断及鉴别诊断[J].浙江中西医结合杂志,2016,26(4):360-362. [7]刘文慧,曾艳,徐云霞,等.胰腺囊性病变的MRI诊断[J].安徽医学,2017,38(3):316-319. [8]Sahani D,Prasad S,Saini S,et al.Cystic pancreatic neoplasms evaluation by CT and magnetic resonance cholangiopancreatography[J].Gastrointest Endosc Clin N Am,2015,12(3):657-672. [9]Kubo H,Chijiiwa Y,Akahoshi K,et al.Intraductal papillary-mucinous tumors of the pancreas:differential diagnosis between benign and malignant tumors by endoscopic ultrasonography[J].Am J Gastroenterol,2014,96(7):1429-1434. [10]Ogawa H,Itoh S,Ikeda M,et al.Inteaductal papillary mucinous neoplasm of the panreas:asseeement of the likelihood of invasiveness with multisection CT[J].Radiology,2015,248(3):876-886. [11]Sugiyama M,Izumisato Y,Abe N,et al.Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas[J].Br J Surg,2018,90(10):1244-1249. [12]Fukukura Y,Fujiyoshi F,Sasaki M,et al.Intradutal papillarym mucinous tumors of the pancreas:thin-section helical CT findings[J].Am J Roentgenol,2016,174(2):441-447. [13]Taouli B,Vilgrain V,Vullierme MP,et al.Intraducctal papillary muccinous tumors of the pancreas:helical CT with histopathologicc correlation[J].Radiology,2015,217(3):757-764. [14]王伟,张飞雄,李兆申.胰腺肿瘤标志物的研究进展[J].世界华人消化杂志,2007,15(5):3604-3610.

相似文献/References:

[1]张熠霖,皇晓燕,赵滢滢,等.糖尿病胰岛病变及胰岛β细胞胰岛素分泌损伤检测的整合实验相关经验探讨[J].医学信息,2019,32(01):18.[doi:10.3969/j.issn.1006-1959.2019.01.006]
 ZHANG Yi-lin,HUANG Xiao-yan,ZHAO Ying-ying,et al.Experience in the Integration Experiment of Diabetic Islet Lesions and Islet β-cell Insulin Secretion Damage Detection[J].Journal of Medical Information,2019,32(14):18.[doi:10.3969/j.issn.1006-1959.2019.01.006]

更新日期/Last Update: 2019-07-15